To improve security and privacy, we are moving our web pages and services from HTTP to HTTPS.
To give users of web services time to transition to HTTPS, we will support separate HTTP and HTTPS services until the end of 2017.
From January 2018 most HTTP traffic will be automatically redirected to HTTPS. [more...]
View this page in https
PROSITE documentation PDOC00351

Disintegrin domain signature and profile





Description

Disintegrins [1,2] are snake venom proteins which inhibit fibrinogen interaction with platelet receptors expressed on the glycoprotein IIb-IIIa complex. They act by binding to the integrin glycoprotein IIb-IIIa receptor on the platelet surface and inhibit aggregation induced by ADP, thrombin, platelet-activating factor and collagen.

Disintegrins are peptides of about 70 amino acid residues that contain many cysteines all involved in disulfide bonds [3]. Disintegrins contain an Arg-Gly-Asp (RGD) sequence, a recognition site of many adhesion proteins. The RGD sequence of disintegrins is postulated to interact with the glycoprotein IIb-IIIa complex.

The sequences of disintegrins from different snake species are known. These proteins are known as: albolabrin, applagin, barbourin, batroxostatin, bitistatin, echistatin, elegantin, eristicophin, flavoridin, halysin, kistrin, tergeminin and triflavin.

Some other proteins are known to contain a disintegrin domain:

  • Some snake venom zinc metalloproteinases [4] consist of an N-terminal catalytic domain fused to a disintegrin domain. Such is the case for trimerelysin I (HR1B), atrolysin e (Ht-e) and trigramin. It has been suggested that these proteinases are able to cleave themselves from the disintegrin domains and that the latter may arise from such a post- translational processing.
  • ADAM type metalloproteases (see <PDOC50215>).
  • Mammalian epididymial protein 1 (EAP I) [6]. EAP I is associated with the sperm membrane and may play a role in sperm maturation. Structurally, EAP I consists of an N-terminal domain, followed by a zinc metalloproteinase domain, a disintegrin domain, and a large C-terminal domain that contains a transmembrane region.

The schematic representation of the structure of a typical disintegrin domain is shown below:

                              +-----+
                +-------------|-----|--+        +------------------+
                |             |     |  |        |                  |
  xxxxxCxCxxxxxxCCxxxxCxxxxxxxCxxxxCCxxCxxxxxxxxCxxxRGDxxxxxCxxxxxxCxxxxxxx
       | |       |    |       *****|**************          |
       +-|-------|----+            +------------------------+
         +-------+
'C': conserved cysteine involved in a disulfide bond.
'*': position of the pattern.

Short disintegrins lack the N-terminal of the domain.

As a signature pattern for the disintegrin domain, we selected a conserved central region that contains five of the cysteines involved in disulfide bonds. A profile was also developed that spans the whole domain.

Last update:

April 2006 / Pattern revised.

Technical section

PROSITE methods (with tools and information) covered by this documentation:

DISINTEGRIN_2, PS50214; Disintegrin domain profile  (MATRIX)

DISINTEGRIN_1, PS00427; Disintegrins signature  (PATTERN)


References

1AuthorsWilliams J., Rucinski B., Holt J., Niewiarowski S.
TitleElegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor.
SourceBiochim. Biophys. Acta 1039:81-89(1990).
PubMed ID2191722

2AuthorsDennis M.S., Henzel W.J., Pitti R.M., Lipari M.T., Napier M.A., Deisher T.A., Bunting S., Lazarus R.A.
TitlePlatelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
SourceProc. Natl. Acad. Sci. U.S.A. 87:2471-2475(1990).
PubMed ID2320569

3AuthorsCalvete J.J., Schafer W., Soszka T., Lu W.Q., Cook J.J., Jameson B.A., Niewiarowski S.
TitleIdentification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity.
SourceBiochemistry 30:5225-5229(1991).
PubMed ID2036389

4AuthorsHite L.A., Fox J.W., Bjarnason J.B.
TitleA new family of proteinases is defined by several snake venom metalloproteinases.
SourceBiol. Chem. Hoppe-Seyler 373:381-385(1992).
PubMed ID1515064

5AuthorsBlobel C.P., Wolfsberg T.G., Turck C.W., Myles D.G., Primakoff P., White J.M.
TitleA potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion.
SourceNature 356:248-252(1992).
PubMed ID1552944
DOI10.1038/356248a0

6AuthorsPerry A.C.F., Jones R., Barker P.J., Hall L.
TitleA mammalian epididymal protein with remarkable sequence similarity to snake venom haemorrhagic peptides.
SourceBiochem. J. 286:671-675(1992).
PubMed ID1417724



PROSITE is copyright. It is produced by the SIB Swiss Institute Bioinformatics. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified. Usage by and for commercial entities requires a license agreement. For information about the licensing scheme send an email to
Prosite License or see: prosite_license.html.

Miscellaneous

View entry in original PROSITE document format
View entry in raw text format (no links)